| Serial Number | 79232153 |
| Word Mark | INTRABIO |
| Filing Date | Wednesday, February 14, 2018 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, January 10, 2019 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; drugs for medical purposes; drugs for medical purposes, namely, the prevention and treatment of neurodegenerative diseases; drugs for medical purposes, namely, the prevention and treatment of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; reagents for use in medical genetic testing; diagnostic reagents for medical laboratory use; diagnostic reagents for medical laboratory use, namely, use in the detection and identification of neurodegenerative diseases; diagnostic reagents for medical laboratory use, namely, use in the detection and identification of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; amino acid preparations for medical purposes; amino acid preparations for pharmaceutical use |
| Goods and Services | Scientific and technological services and research and design relating thereto; industrial analysis and research services; scientific and technological services and research in the field of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; industrial analysis and research services related to neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy, design and development of computer hardware and software related to assays; clinical trials; conducting clinical trials for pharmaceutical products; conducting clinical trials for neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; medical laboratories for research related to neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; providing information about the results of clinical trials for pharmaceutical products; clinical research; medical laboratories; research relating to molecular sciences; medical research; genetic research; research in the field of gene therapy; biopharmaceutical research for development of targeted therapies for use in the treatment of carcinomas and neurodegenerative diseases; scientific, biochemical, research and development services in the field of neurodegenerative diseases; providing scientific information in the field of medical disorders and their treatment; pharmaceutical drug development services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 21, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 21, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | IntraBio Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 11 - Company |
| Address | GB |
| Event Date | Event Description |
| Friday, January 31, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, January 10, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, January 10, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, November 8, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, October 23, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 23, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Friday, January 11, 2019 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Thursday, January 10, 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Saturday, June 30, 2018 | REFUSAL PROCESSED BY IB |
| Thursday, June 14, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, June 14, 2018 | REFUSAL PROCESSED BY MPU |
| Thursday, June 7, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, June 6, 2018 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 30, 2018 | ASSIGNED TO EXAMINER |
| Friday, May 25, 2018 | APPLICATION FILING RECEIPT MAILED |
| Monday, May 21, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, May 17, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |